Management of a center focused on targeted therapeutics
Official title: Admin-Core
Funded at University of South Carolina at Columbia · NIH-10936194 · Data updated 2026-11-12
This study is all about supporting new research projects that aim to create better treatments for patients, so you could have more options for managing your condition in the future.
Quick facts
| Grant type | P30 center grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of South Carolina at Columbia NIH-funded |
| Lab location | 1 site (Columbia, United States) |
| Project start | July 15, 2024 |
| Project end | May 31, 2029 |
| Funding year | 2024 |
| Award (this year) | $422,086 |
| NIH project number | 1P30GM154632-01 |
| Project ID | NIH-10936194 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include individuals with conditions that could be addressed by targeted therapeutics.
✕Less likely to help
Patients with conditions unrelated to targeted therapeutics may not receive any benefit from this research.
What this research studies
This research involves the administration of the Center for Targeted Therapeutics at the University of South Carolina. The Administrative Core will oversee organizational, fiscal, and scientific aspects, ensuring effective communication and evaluation of the center's activities. It will also manage a Pilot Project program that funds innovative research projects aimed at developing new targeted therapies. Patients may benefit from the advancements in treatment options that arise from these funded projects.
Why it matters
Potential benefit: If successful, this research could lead to the development of new targeted therapies that improve treatment outcomes for patients.
How similar studies have gone: Other research initiatives focused on targeted therapeutics have shown promise in developing effective treatments, indicating a potential for success in this approach.
Where this research is happening
-
University of South Carolina at Columbia
Columbia, United States Active
Researchers
- Principal investigator: Kiaris, Hippokratis — University of South Carolina at Columbia
- Study coordinator: Kiaris, Hippokratis
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.